BTAI Igalmi Patents And Comparison to Precedex
- BPIQ
- Feb 5, 2023
- 5 min read
The active ingredient in BTAI's platform in a drug, Igalmi (BXCL 501), is the drug dexmedetomidine, which has been available since 1999 and is now used for intravenous administration before intubation. It is available under the brand Precedex, which is available as a generic (https://www.drugs.com/price-guide/precedex). It's chemical structure is well known^1.